All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @jovan_bradley on Instagram · 103s|Watch on Instagram
Full video transcriptClick to expand

Auto-generated transcript of @jovan_bradley's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00What do you think the process of gender affirming care is?
  2. 0:03It's a multi-level process.
  3. 0:05I believe it can be just purely psychological,
  4. 0:08but therapy-based hormone blocker
  5. 0:11is it possibly on that.
  6. 0:13Fury blockers, hormone replacement therapy,
  7. 0:15there's cosmetic surgery that is done on that.
  8. 0:18But the general theme that I would say
  9. 0:20on that I disagree with is the actual,
  10. 0:24well, the entire premise of gender affirming care.
  11. 0:27So that's implying that we are affirming the desire
  12. 0:33gender of an individual who is experiencing distress
  13. 0:37because of this.
  14. 0:38Which form of gender affirming care
  15. 0:40are you specifically against minors receiving?
  16. 0:43Like, what specific type of care?
  17. 0:46So let me draw the line of exactly.
  18. 0:48So if there is care that is, let me say,
  19. 0:50which would be, I would believe, only lying in therapy.
  20. 0:54But if there's care that is leaning towards on the side of,
  21. 0:57hey, this is a psychological problem that you're having.
  22. 1:00Let's help work you through this.
  23. 1:01Maybe get more comfortable with the person that you are.
  24. 1:04Is what I'm perfectly fine with,
  25. 1:06where I draw the line is affirming said psychological
  26. 1:13disorder as if it is biologically true.
  27. 1:17There's a lot of misconceptions here that I wanna tackle.
  28. 1:19One, the care you say you're for is conversion therapy,
  29. 1:23which has been shown to increase suicide,
  30. 1:25suicidality, depression, anxiety, social disorders.
  31. 1:30So that would be conversion therapy, right?
  32. 1:34Trying to tell a trans person to just be happy
  33. 1:36with the body they have or who they are
  34. 1:39and essentially telling them not to be trans,
  35. 1:42that's conversion therapy.

@jovan_bradley's gender-affirming care claims, fact-checked

Jovan Bradley

Instagram creator

12.2K viewsView on Instagram

Quick answer

The creator conflates gender dysphoria, a recognized clinical condition with documented neurobiological correlates, with a purely psychological disorder that should be treated by redirecting identity rather than affirming it. This position contradicts current clinical consensus from the Endocrine Society and WPATH, both of which treat gender dysphoria with identity-affirming protocols based on outcome data. The distinction matters practically because the alternative he proposes, therapy aimed at comfort with birth sex, meets the clinical and legal definition of conversion therapy in many jurisdictions and carries documented suicide risk.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 3 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @jovan_bradley's gender-affirming care claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@jovan_bradley's gender-affirming care claims, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@jovan_bradley's gender-affirming care claims, fact-checked" from Jovan Bradley. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator conflates gender dysphoria, a recognized clinical condition with documented neurobiological correlates, with a purely psychological disorder that should be treated by redirecting identity rather than affirming it.

The reason this review is not generic is the source wording and the canonical claim label "trt the true process of gender affirming care is complex from t." In this clip, the useful excerpt is: "What do you think the process of gender affirming care is?" That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Therapy aimed at making trans people comfortable with their birth-assigned sex meets the clinical and legal definition of conversion therapy in many U.
People who land here are usually comparing the Testosterone claim with GenderAffirmingCare, MentalHealth, and Therapy.
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator conflates gender dysphoria, a recognized clinical condition with documented neurobiological correlates, with a purely psychological disorder that should be treated by redirecting identity rather than affirming it.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator conflates gender dysphoria, a recognized clinical condition with documented neurobiological correlates, with a purely psychological disorder that should be treated by redirecting identity rather than affirming it. This position contradicts current clinical consensus from the Endocrine Society and WPATH, both of which treat gender dysphoria with identity-affirming protocols based on outcome data. The distinction matters practically because the alternative he proposes, therapy aimed at comfort with birth sex, meets the clinical and legal definition of conversion therapy in many jurisdictions and carries documented suicide risk.
  • A 2022 Tordoff et al. study in JAMA Network Open found gender-affirming care was associated with 60% lower odds of moderate to severe depression in trans youth over one year.
  • Therapy aimed at making trans people comfortable with their birth-assigned sex meets the clinical and legal definition of conversion therapy in many U.S. states and countries.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • A 2022 Tordoff et al. study in JAMA Network Open found gender-affirming care was associated with 60% lower odds of moderate to severe depression in trans youth over one year.
  • Therapy aimed at making trans people comfortable with their birth-assigned sex meets the clinical and legal definition of conversion therapy in many U.S. states and countries.
  • Puberty blockers used in gender-affirming care are GnRH agonists, the same class of drugs used for decades to treat precocious puberty, and are described as reversible by the Endocrine Society.
  • A 2018 Burke et al. review in Endocrine Practice identified neurological and hormonal patterns in transgender individuals that align with their identified gender, not birth-assigned sex, complicating any purely psychological framing.
  • WPATH Standards of Care Version 8 (2022) requires persistent documented dysphoria, psychological evaluation, and typically social transition before medical intervention is considered for minors, not a fast-track process.
  • Green et al. (2019, The Trevor Project) found transgender youth with at least one accepting parent had 40% lower odds of attempting suicide compared to those without parental acceptance.
  • The biological basis of gender identity is not fully resolved in research, but the available evidence, including twin studies and neuroimaging, does not support the claim that it is purely a psychological construct.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @jovan_bradley actually say?

The creator laid out a position that sits somewhere between outright opposition and conditional acceptance. He said he supports therapy that helps someone "get more comfortable with the person that you are" but draws the line at "affirming said psychological disorder as if it is biologically true." His interlocutor pushed back, correctly identifying that position as conversion therapy. To his credit, @jovan_bradley did not dismiss the label outright.

What he is actually arguing is a two-part claim: first, that gender dysphoria is a psychological disorder rather than a condition with a biological basis; second, that affirming a trans identity constitutes medically unsound treatment. Both claims are contested by the weight of current clinical evidence, and the second has been specifically evaluated in outcome research. The framing that gender-affirming care is built on a "misunderstood premise" is the central assertion this fact-check will examine.

Does the science back this up?

No, not in any straightforward way. The biological basis for gender identity is not fully mapped, but dismissing it as purely psychological contradicts what researchers have actually found. Multiple lines of evidence, including neuroimaging, twin studies, and endocrine research, point to a biological component.

A 2018 review by Burke et al. in Endocrine Practice summarized evidence that transgender individuals show neurological and hormonal patterns that differ from their birth-assigned sex and align more closely with their identified gender. A 2020 genome-wide association study by Ganna et al. in Science identified genetic variants associated with gender nonconformity, though researchers cautioned that genetics alone do not determine gender identity. Calling it a "psychological disorder" with no biological substrate is not a position supported by the American Psychological Association, the American Academy of Pediatrics, or the World Professional Association for Transgender Health. None of that means the science is settled. It means the evidence leans against @jovan_bradley's framing, not toward it.

What did they get wrong (or right)?

He got the conversion therapy criticism mostly wrong, and his interlocutor got it mostly right. When you tell a trans person to work toward being comfortable in a body they experience as wrong, without affirming their identity, that is functionally conversion therapy regardless of whether it uses aversive techniques.

Research is consistent on outcomes. A 2020 study by Blosnich et al. in JAMA Psychiatry found that exposure to conversion practices was associated with significantly higher odds of lifetime suicide attempts. A 2019 study by Green et al. published by The Trevor Project found that transgender youth who reported having a parent who was accepting of their gender identity had 40% lower odds of attempting suicide. @jovan_bradley's proposed alternative, therapy aimed at alignment with birth sex, is not a neutral clinical option. It carries documented risks.

Where he is not entirely wrong: the process of gender-affirming care does involve multiple steps, and not every minor who presents with gender dysphoria will pursue medical intervention. That part of his description is accurate.

What should you actually know?

Gender-affirming care is not a single procedure or a fast track to surgery. Clinical guidelines from WPATH and the Endocrine Society require persistent, well-documented dysphoria, psychological evaluation, and typically a period of social transition before any medical intervention is considered for minors. Puberty blockers used in this context, primarily GnRH agonists, are described as reversible and have been used for decades in children with precocious puberty.

The claim that affirming care is built on a flawed premise ignores that its outcomes have been studied. A 2022 study by Tordoff et al. in JAMA Network Open found that gender-affirming care was associated with 60% lower odds of moderate to severe depression and 73% lower odds of suicidality among transgender and nonbinary youth over one year. That is not a rounding error. That is a clinically significant result.

None of this is a settled debate in every detail. Long-term fertility effects of early hormone intervention remain under study. But the core premise that affirming care is harmful or built on a misunderstanding is not supported by outcome data available today.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Jovan Bradley · Instagram creator

12.2K views on this video

The true process of gender-affirming care is complex. From therapy to hormone blockers, it's a multi-level journey. But what if the core premise is misunderstood? #GenderAffirmingCare #MentalHealth #T

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about a 2022 tordoff et al. study in jama network open?

A 2022 Tordoff et al. study in JAMA Network Open found gender-affirming care was associated with 60% lower odds of moderate to severe depression in trans youth over one year.

What does the video say about therapy aimed at making trans people comfortable with their birth-assigned?

Therapy aimed at making trans people comfortable with their birth-assigned sex meets the clinical and legal definition of conversion therapy in many U.S. states and countries.

What does the video say about puberty blockers used in gender-affirming care?

Puberty blockers used in gender-affirming care are GnRH agonists, the same class of drugs used for decades to treat precocious puberty, and are described as reversible by the Endocrine Society.

What does the video say about a 2018 burke et al. review in endocrine practice identified?

A 2018 Burke et al. review in Endocrine Practice identified neurological and hormonal patterns in transgender individuals that align with their identified gender, not birth-assigned sex, complicating any purely psychological framing.

What does the video say about wpath standards of care version 8 (2022) requires persistent documented?

WPATH Standards of Care Version 8 (2022) requires persistent documented dysphoria, psychological evaluation, and typically social transition before medical intervention is considered for minors, not a fast-track process.

What does the video say about green et al. (2019, the trevor project) found transgender youth?

Green et al. (2019, The Trevor Project) found transgender youth with at least one accepting parent had 40% lower odds of attempting suicide compared to those without parental acceptance.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Jovan Bradley, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.